Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC.BIO, BIOB · Entity 2247 | Executive Vice President | September 12, 2019 | September 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-RAD LABORATORIES, INC.
Report date September 12, 2019 · Filed September 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 18,728 |
Ending reported balance
After 2019-09-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2019-09-12 · Exercise / conversion · Acquired 600 · Balance 18,966 Row 2 · 2019-09-12 · Exercise / conversion · Acquired 600 · Balance 19,566 Row 3 · 2019-09-12 · Sale · Disposed 797 · Balance 18,769 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.00 to $328.70, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2019-09-12 · Sale · Disposed 41 · Balance 18,728 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $119.54 · Expires 2024-09-10 | Direct | 0 |
Reported balance
After 2019-09-12 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-09-12 · Exercise / conversion · Disposed 600 · Balance 0 F2: The option vests in five equal annual installments beginning September 10, 2015. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $139.56 · Expires 2025-09-11 | Direct | 600 |
Reported balance
After 2019-09-12 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-09-12 · Exercise / conversion · Disposed 600 · Balance 600 F3: The option vests in five equal annual installments beginning September 11, 2016. |
| Bio-Rad A Common StockSEC Table I · non-derivative | IndirectBy Spouse | 252 |
Reported balance
Holding disclosure · report date 2019-09-12 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 252 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.00 to $328.70, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The option vests in five equal annual installments beginning September 10, 2015.
F3: The option vests in five equal annual installments beginning September 11, 2016.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2018 Filed Sep 7, 2018 18:43 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000037 · edgar.xml · derivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 5, 2018. Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 18:43 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 208 | $315.50 | $65,624.00 |
DisclosureSEC source: 0001652252-18-000037 · edgar.xml · nonDerivative · entry 2 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,954 Read SEC document |
| September 05, 2018 Filed Sep 7, 2018 18:43 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000037 · edgar.xml · nonDerivative · entry 1 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 19:08 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $326.15 | $0.00 |
DisclosureSEC source: 0001652252-18-000007 · edgar.xml · derivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Bio-Rad A Common Stock · 3,000 shares Expires 2028-09-04 F3 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 19:08 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-18-000007 · edgar.xml · derivative · entry 3 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Bio-Rad A Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:18 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000098 · edgar.xml · derivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:18 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 226 | $218.04 | $49,277.04 |
DisclosureSEC source: 0001652252-17-000098 · edgar.xml · nonDerivative · entry 2 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,562 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:18 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000098 · edgar.xml · nonDerivative · entry 1 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:26 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · derivative · entry 8 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:26 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · derivative · entry 7 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Underlying: Bio-Rad A Common Stock · 700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2013. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2013. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:26 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 490 | $218.86 | $107,241.40 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · nonDerivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,188 Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:26 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · nonDerivative · entry 3 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 10, 2017 Filed Sep 12, 2017 18:26 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · derivative · entry 6 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015. Read SEC document |
| September 10, 2017 Filed Sep 12, 2017 18:26 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 226 | $218.42 | $49,362.92 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · nonDerivative · entry 2 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,378 Read SEC document |
| September 10, 2017 Filed Sep 12, 2017 18:26 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000082 · edgar.xml · nonDerivative · entry 1 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:17 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000066 · edgar.xml · derivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 7, 2017. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 7, 2017. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:17 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 226 | $215.44 | $48,689.44 |
DisclosureSEC source: 0001652252-17-000066 · edgar.xml · nonDerivative · entry 2 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,004 Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:17 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000066 · edgar.xml · nonDerivative · entry 1 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 23:15 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $215.98 | $0.00 |
DisclosureSEC source: 0001652252-17-000046 · edgar.xml · derivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Bio-Rad A Common Stock · 3,000 shares Expires 2027-09-05 F3 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 23:15 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000046 · edgar.xml · derivative · entry 3 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Bio-Rad A Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| November 07, 2016 Filed Nov 8, 2016 18:42 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 227 | $165.62 | $37,595.74 |
DisclosureSEC source: 0001652252-16-000130 · edgar.xml · nonDerivative · entry 2 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,630 F2 · shares: Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 18:42 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000130 · edgar.xml · derivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning November 4, 2012. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning November 4, 2012. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 18:42 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000130 · edgar.xml · nonDerivative · entry 1 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 13, 2016 Filed Sep 14, 2016 19:35 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 228 | $158.08 | $36,042.90 |
DisclosureSEC source: 0001652252-16-000118 · edgar.xml · nonDerivative · entry 2 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,257 F2 · shares: Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:19 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 728 | $155.02 | $112,855.65 |
DisclosureSEC source: 0001652252-16-000110 · edgar.xml · nonDerivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,885 F3 · shares: Sold by the Issuer on behalf of the Reporting Person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.0164 to $155.0314, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 19:35 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000118 · edgar.xml · derivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 19:35 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000118 · edgar.xml · nonDerivative · entry 1 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 11, 2016 Filed Sep 13, 2016 22:19 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000110 · edgar.xml · derivative · entry 8 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F8 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
| September 11, 2016 Filed Sep 13, 2016 22:19 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000110 · edgar.xml · derivative · entry 7 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Underlying: Bio-Rad A Common Stock · 700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. F7 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. Read SEC document |
| September 11, 2016 Filed Sep 13, 2016 22:19 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000110 · edgar.xml · nonDerivative · entry 3 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 10, 2016 Filed Sep 13, 2016 22:19 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000110 · edgar.xml · derivative · entry 6 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015. F6 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015. Read SEC document |
| September 10, 2016 Filed Sep 13, 2016 22:19 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000110 · edgar.xml · nonDerivative · entry 2 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:19 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 2,689 | $158.57 | $426,394.73 |
DisclosureSEC source: 0001652252-16-000110 · edgar.xml · nonDerivative · entry 1 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,713 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.55 to $158.63, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 07, 2016 Filed Sep 9, 2016 19:10 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $159.32 | $0.00 |
DisclosureSEC source: 0001652252-16-000087 · edgar.xml · derivative · entry 4 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Bio-Rad A Common Stock · 3,000 shares Expires 2026-09-07 F3 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 07, 2016 Filed Sep 9, 2016 19:10 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000087 · edgar.xml · derivative · entry 3 HERTIA JOHN · CIK 0001616003 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Bio-Rad A Common Stock · 3,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.